An Essential Role of Hrs/Vps27 in Endosomal Cholesterol Trafficking  by Du, Ximing et al.
Cell Reports
ReportAn Essential Role of Hrs/Vps27
in Endosomal Cholesterol Trafficking
Ximing Du,1 Abdulla S. Kazim,1 Andrew J. Brown,1 and Hongyuan Yang1,*
1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia
*Correspondence: h.rob.yang@unsw.edu.au
DOI 10.1016/j.celrep.2011.10.004SUMMARY
The endosomal sorting complex required for trans-
port (ESCRT) plays a crucial role in the degradation
of ubiquitinated endosomal membrane proteins.
Here, we report that Hrs, a key protein of the
ESCRT-0 complex, is required for the transport of
low-density lipoprotein-derived cholesterol from en-
dosomes to the endoplasmic reticulum. This function
of Hrs in cholesterol transport is distinct from its
previously defined role in lysosomal sorting and
downregulation of membrane receptors via the
ESCRT pathway. In line with this, knocking down
other ESCRT proteins does not cause prominent
endosomal cholesterol accumulation. Importantly,
the localization and biochemical properties of key
cholesterol-sorting proteins, NPC1 and NPC2,
appear to be unchanged upon Hrs knockdown. Our
data identify Hrs as a regulator of endosomal choles-
terol trafficking and provide additional insights into
the budding of intralumenal vesicles.INTRODUCTION
Mammalian cells acquire exogenous cholesterol through
receptor-mediated endocytosis of low-density lipoproteins
(LDLs) (Brown and Goldstein, 1986). The endocytic pathway
sorts and delivers LDL from early endosomes to late endo-
somes/lysosomes (LE/Ly) for the hydrolysis of cholesteryl esters,
and the released free cholesterol exits LE/Ly efficiently to reach
the plasmamembrane and/or the endoplasmic reticulum (ER) for
structural and regulatory functions (Chang et al., 2006; Ikonen,
2008; Kristiana et al., 2008; Mesmin and Maxfield, 2009).
Niemann Pick type C (NPC) 1 and NPC2 are two key proteins
that regulate the exit of LDL-derived cholesterol (LDL-C) from
LE/Ly. Recent elegant studies suggest that NPC2 (a soluble,
cholesterol binding protein that resides in the lysosomal lumen)
accepts and delivers LDL-C to the N-terminal domain of NPC1
(an LE/Ly membrane protein with 13 transmembrane domains
and three large lumenal loops), which then inserts LDL-C directly
into the lysosomal membrane for export (Kwon et al., 2009).
Putative proteins on the cytoplasmic side of the endosomal
limiting membrane may be required to transport LDL-C to other
membranes (Kwon et al., 2009; Yang, 2006). We have recently
identified ORP5, an oxysterol binding protein (OSBP)-relatedprotein, as a possible key component in the post-LE/Ly transport
of LDL-C (Du et al., 2011). It is likely that other yet-to-be identified
proteins may also work with ORP5 to remove cholesterol from
the endosomes.
We have focused on components of the endosomal sorting
complex required for transport (ESCRT) (Saksena et al., 2007),
which mediates the degradation of ubiquitinated endosomal
membrane proteins through the formation of intralumenal
vesicles (ILVs) (Hurley, 2010; Hurley and Hanson, 2010; Raiborg
and Stenmark, 2009; Williams and Urbe´, 2007). ESCRT consists
of a highly conserved set of four hetero-oligomeric protein
complexes (ESCRT-0, -I, -II, and -III) comprising more than
a dozen subunits. ESCRT-0 is believed to sequester ubiquiti-
nated cargo and recruit other ESCRT complexes. Recent
elegant in vitro studies demonstrate that ESCRT-I and II can
drive membrane deformation to form the ILVs whereas
ESCRT-III is important for the abscission of the forming ILVs
(Wollert and Hurley, 2010; Wollert et al., 2009). The AAA
ATPase VPS4/SKD1 regulates the disassembly and recycling
of ESCRT-III components, enabling further rounds of cargo
sorting. There have been a few lines of evidence linking ESCRT
function and cholesterol trafficking. We and others have shown
that VPS4 can interact with yeast ORPs and regulate cholesterol
sorting in yeast and mammalian cells (Bishop and Woodman,
2000; Wang et al., 2005; Yang, 2006). Overexpression of hSnf7
and hVps20 has been reported to cause endosomal cholesterol
accumulation (Peck et al., 2004). A close functional relationship
between ORPs and ESCRT function has been revealed in
Caenorhabditis elegans (Kobuna et al., 2010). Interestingly,
a recent study demonstrated that ORP5 specifically bound to
the ubiquitin-interacting motif of Hrs (hepatocyte growth
factor-regulated tyrosine kinase substrate, called VPS27 in yeast
for vacuolar protein sorting 27) (Pridgeon et al., 2009). Hrs
interacts with STAM (signal transducing adaptor molecule) to
make up ESCRT-0, which plays a crucial role in initiating the
ESCRT pathway (Bache et al., 2003b; Bilodeau et al., 2002).
ESCRT-0 recruits ESCRT-I possibly through the direct interac-
tion between Hrs and Tsg101(an ESCRT-I component that also
binds ubiquitinated proteins), and hands the ubiquitinated cargo
to ESCRT-I (Bache et al., 2003a; Bilodeau et al., 2003; Katzmann
et al., 2003; Lu et al., 2003).
Here, we report that Hrs, but not other ESCRT-0, -I, -II, or -III
subunits, is required for the transport of LDL-C from endo-
somes to the ER. Our data indicate that Hrs regulates
endosomal cholesterol transport independent of NPC1 and
NPC2, and therefore identify Hrs as a regulator of cholesterol
trafficking.Cell Reports 1, 29–35, January 26, 2012 ª2012 The Authors 29
Figure 1. Hrs Knockdown Causes LDL-
Derived Cholesterol Accumulation in HeLa
Cells
(A) HeLa cells were transfected with two siRNAs
targeting different regions of Hrs (siHrs.1, siHrs.2),
siNPC1 or a universal control siCtrl for 72 hr. Effi-
ciency of knockdown was analyzed by immuno-
blotting using polyclonal anti-NPC1, monoclonal
anti-Hrs, or anti-actin antibodies.
(B) HeLa cells were transfected with indicated
siRNAs for 72 hr. Cells were then fixed and stained
by filipin for free cholesterol. Representative fluo-
rescent images are shown.
(C) Filipin intensities of cells from (B) were
measured using ImageJ and the values were
normalized to those of control images (mean ± SD,
n > 30).
(D) HeLa cells were transfected with siCtrl or siHrs
for 54 hr, followed by incubation in medium A
(FBS), medium B (LPDS), or medium B supple-
mented with 50 mg/ml of LDL (LPDS + LDL). Cells
were then fixed and stained by filipin for free
cholesterol.
(E) Filipin intensities of cells from (D) were
measured using ImageJ and the values were
normalized to those of control cells grown in FBS
medium (mean ± SD, n > 30). Bars = 10 mm.RESULTS AND DISCUSSION
Hrs Knockdown Causes Endosomal Accumulation
of LDL-Derived Cholesterol
We have recently shown that ORP5 plays an important role in en-
dosomal cholesterol transport (Du et al., 2011). The possible link
between ORP5 and Hrs (Pridgeon et al., 2009) prompted us to
investigate whether Hrs and other ESCRT components may
regulate intracellular cholesterol transport and homeostasis.
Strikingly, an NPC-like cholesterol accumulation phenotype
was observed in HeLa cells when Hrs was depleted by either
of the two distinct siRNA oligos (Figures 1A–1C). Both free and
total cholesterol was increaseduponHrs knockdown (Figure S1A
available online). The accumulation of cholesterol in Hrs knock-
down cells is dependent on the presence of LDL (Figures 1D
and 1E), indicating that Hrs may regulate the transport of
LDL-C in HeLa cells. To test whether Hrs silencing causes the
accumulation of LDL-C in LE/Ly, we investigated the colocaliza-
tion between accumulated free cholesterol and the late endo-
somal marker, Lamp-1. Cholesterol mainly accumulated in
Lamp-1-positive compartment in Hrs knockdown cells, similar
to that in NPC1 knockdown cells (Figures S1B and S1C). Choles-
terol in Hrs knockdown cells colocalized mainly with GFP-Rab7
and partially with GFP-Rab5 or GFP-EEA1 (Figures S1D and
S1E), further indicating that Hrs depletion resulted in late endo-
somal accumulation of free cholesterol. Together, these data
indicate that Hrs is specifically involved in endosomal transport
of LDL-C in HeLa cells.
Hrs Has a Distinct Role in Endosomal
Cholesterol Transport
To investigate whether other ESCRT components may also
regulate cholesterol trafficking, HeLa cells were treated with30 Cell Reports 1, 29–35, January 26, 2012 ª2012 The AuthorssiRNAs targeting Hrs and selected ESCRT subunits: Hrs
(ESCRT-0), Tsg101 (ESCRT-I), EAP20 (ESCRT-II), and CHMP6
(ESCRT-III) (Figure 2A). Among these ESCRT subunits, only
Hrs appears to be involved in cholesterol transport, since the
downregulation of other ESCRT subunits in HeLa cells did
not cause any apparent cholesterol accumulation (Figure 2B).
We carefully examined the effect of Tsg101 knockdown
because Hrs and Tsg101 are closely related, both functionally
and physically (Bache et al., 2003a; Lu et al., 2003). Tsg101
was efficiently depleted after siRNA transfection as indicated
by immunoblotting (Figure 2C), and by the enlargement and/
or clustering of Lamp-1-positive compartments that indicates
impaired Tsg101 function as previously described (Doyotte
et al., 2005; Figure 2D). To further ensure that Tsg101 is effec-
tively knocked down, we examined the trafficking of caveolin-1
(CAV1) tagged with mEGFP and mCherry at its C terminus
(Hayer et al., 2010) in Hrs and Tsg101 single or double knock-
down cells. Consistent with the previous report, most of LE/Ly
compartments were red in control cells (Figure S2A), whereas
both red and green LE/Ly compartments were observed in cells
depleted of Hrs or Tsg101 due to defects in ILV targeting of
CAV1 (Figures S2B and S2C). This phenotype became more
severe in HeLa cells depleted of both Hrs and Tsg101 (Fig-
ure S2D, line profile). These results indicate that the function
of Tsg101 is compromised by siRNA, but cholesterol transport
is not, further supporting the distinct role of Hrs in cholesterol
trafficking.
A recent study revealed a close relationship between sorting
nexin 3 (SNX3) and Hrs (Pons et al., 2008). Interestingly,
silencing of SNX3 in HeLa cells appeared to have no effect
on cholesterol transport (Figures S2E and S2F). We also
knocked down VPS26 (Figure S2G), a component of the retro-
mer complex that associates with endosomes and mediates
Figure 2. Hrs Is Specifically Involved in
Intracellular Cholesterol Trafficking
(A) HeLa cells were transfected with siRNAs tar-
geting Hrs (ESCRT-0), Tsg101 (ESCRT-I), EAP20
(ESCRT-II), or CHMP6 (ESCRT-III) for 72 hr. Effi-
ciency of knockdown was analyzed by qRT-PCR
(means ± SD, n = 3 replicate cultures).
(B) HeLa cells were transfected with the indicated
siRNAs for 72 hr. Cells were then fixed and stained
by filipin for free cholesterol. Representative fluo-
rescent images are shown.
(C) HeLa cells were transfected with siHrs,
siTsg101, or a universal control siCtrl for 72 hr.
Efficiency of knockdown was analyzed by immu-
noblotting using monoclonal anti-Hrs, anti-
Tsg101, or anti-actin antibodies.
(D) HeLa cells were transfected with the indicated
siRNAs for 72 hr, followed by processing for
immunofluorescence staining with themonoclonal
antibody to Lamp-1 and filipin staining for free
cholesterol. Representative confocal images are
shown. Bars = 10 mm.endosomes to trans-Golgi trafficking (Bonifacino and Hurley,
2008). Consistent with a previous report (Arighi et al., 2004),
VPS26 depletion caused a dispersed distribution of cation-
independent mannose 6-phosphate receptor (CI-MPR) in
HeLa cells (Figure S2H). However, no detectable defects in
cholesterol distribution upon VPS26 knockdown were ob-
served in HeLa cells (Figure S2H). Taken together, these data
indicate that Hrs has a unique role in endosomal cholesterol
trafficking.
Hrs Is Required for LDL-C Transport to the ER
Tomonitor the arrival of LDL-C at the ER, HeLa cells depleted for
Hrs were incubated with LDL, followed by examining the conver-
sion of cholesterol to cholesteryl ester that is catalyzed by the
ER-localized enzyme: ACAT (acyl coA cholesterol acyl trans-
ferase). NPC1 knockdown in HeLa cells ablated LDL-induced
cholesterol esterification (Figure 3A, lane 3). Similar to NPC1
knockdown, Hrs depletion also significantly decreased LDL-
induced cholesterol esterification (Figure 3A, lanes 3 and 4
versus lane 2, Figure 3B), indicating a blockage of endosomal
cholesterol transport to the ER. The lack of LDL-C in the ER as
indicated by the cholesterol esterification assay was further
confirmed by the sterol-regulatory element binding protein
(SREBP)-2 processing assay. Cholesterol-loading in the ERCell Reports 1, 29–3blocks the transport of SREBP-2
precursor from the ER to the Golgi
complex for proteolytic cleavage, inhibit-
ing the formation of nuclear form of
SREBP-2 (nSREBP-2) and inactivating
genes involved in cholesterol uptake
and synthesis (Goldstein et al., 2006).
SREBP-2 processing was revealed by
immunoblotting using an antibody (IgG-
1D2) against both precursor and
nSREBP-2 (Figure 3C). As expected,
NPC1 silencing impeded LDL-C trans-port to the ER because the nuclear form of SREBP-2 was still
produced in the presence of LDL (Figure 3C, lane 4 versus lane
2, and Figure 3D). Consistent with the results from cholesterol
esterification assay (Figures 3A and 3B), Hrs knockdown also
blocked LDL-C transport to the ER and abolished the inhibitory
effect of LDL on SREBP-2 processing (Figure 3C, lane 6 versus
lane 2, and Figure 3D). This effect was further tested using
qRT-PCR to examine the expression of two SREBP-dependent
genes: LDL receptor (LDLR) and 3-hydroxy-3-methyglutaryl-
CoA reductase (HMGR). Under control conditions, LDL treat-
ment almost completely shut down LDLR or HMGR expression
(Figure 3E); however, when NPC1 or Hrs was depleted, the inhib-
itory effect of LDL on LDLR or HMGR expression was signifi-
cantly reduced (Figure 3E). Collectively, these data demonstrate
a deficiency of LDL-C transport to the ER when Hrs is depleted,
further supporting that Hrs is required for this process.
NPC1 and NPC2 Still Localize to LE/Ly upon
Hrs Depletion
NPC1 and NPC2 work in concert to deliver LDL-C out of LE/Ly
membranes. Hrs knockdown may interfere with the level and
localization of NPC1 or NPC2, thereby indirectly causing choles-
terol accumulation in LE/Ly compartments. However, the levels
of NPC1 and NPC2 were not compromised upon Hrs depletion5, January 26, 2012 ª2012 The Authors 31
Figure 3. Hrs Is Required for LDL-Derived Choles-
terol Transport to the Endoplasmic Reticulum
(A) HeLa cells grown in medium A were transfected with
siNPC1, siHrs, or a universal control siCtrl for 48 hr, fol-
lowed by incubation in mediumB for 18 hr. Cells were then
chased with LDL (50 mg/ml) and [14C]-palmitate in medium
B for 7 hr. Lipids extracted from cell lysates were stan-
dardized for total cell proteins and separated by TLC.
Cholesteryl [14C]-esters were revealed by phosphor-
imaging. A representative phosphorimage of three
experiments with similar results is shown.
(B) Quantification of cholesteryl [14C]-esters formed in (A)
by densitometry. Values of siCtrl + LDL were arbitrarily set
as 100, against which experimental data were normalized.
The results are expressed as means ± SD from three
independent experiments.
(C) HeLa cells grown in medium A were transfected with
siNPC1, siHrs, or a universal control siCtrl for 48 hr, fol-
lowed by incubation in mediumB for 18 hr. Cells were then
treated with LDL (50 mg/ml) in medium B for 6 hr. Whole
cell lysates were subjected to SDS-PAGE and immuno-
blotting with a monoclonal antibody (IgG-1D2) against
both precursor (P) and nuclear forms (N) of SREBP-2. The
membrane was stripped and reblotted with antibodies to
NPC1, Hrs, and actin.
(D) Relative intensity of theN band relative to the total (N+P
bands) in (C) was quantified by densitometry and pre-
sented relative to none LDL-treated control in each siRNA
treatment. The results are expressed as means ± SD from
three independent experiments.
(E) qRT-PCR analysis of cells with the same treatment in
(C). mRNA levels for LDL-receptor (LDLR) or HMG-CoA
reductase (HMGR) were measured and normalized
to actin mRNA levels. Data are presented relative to no
LDL-treated control in each siRNA treatment and are
means ± SD (n = 3 replicate cultures).(Figure S3). In fact, whereas NPC2 appeared to be unchanged
(Figures S3A and S3B), NPC1 was upregulated in Hrs knock-
down cells in a time-dependent manner (Figures S3C and
S3D). NPC1 or NPC2 may be mislocalized upon Hrs silencing,
which could lead to cholesterol accumulation in LE/Ly. To
examine this possibility, NPC1 localization was investigated by
immunofluorescence in cells treated with control, Hrs or NPC1
siRNAs. In control cells, NPC1 almost completely colocalized
with the LE/Ly marker, Lamp-1 (Figure 4A). Depletion of either
NPC1 or Hrs by siRNA led to the accumulation of free cholesterol
in Lamp-1-positive compartments (Figures 4B and 4C). In Hrs
knockdown cells, NPC1 clearly overlapped with Lamp-1-posi-
tive structures, which encircled the accumulated cholesterol
(Figure 4C, inset). These observations demonstrate that NPC1
is not mislocalized upon Hrs depletion.
To examine NPC2 localization, HeLa cells treated with control
siRNA or siRNAs against NPC1, NPC2, or Hrs were immunola-
beled for endogenous NPC1 and NPC2, and stained with filipin
for free cholesterol. In control cells, NPC1 and NPC2 colocalized
to the same compartments (Figure 4D), which were shown to be
Lamp-1-positive structures (Figures 4A–4C). Cholesterol accu-
mulation in LE/Ly caused by NPC1 depletion overlapped with
NPC2, also confirming the cellular localization of NPC2 (Fig-
ure 4E). This was also the case for NPC1, which overlapped32 Cell Reports 1, 29–35, January 26, 2012 ª2012 The Authorswith the accumulated cholesterol caused by NPC2 depletion
(Figure 4F). Importantly, in Hrs-depleted cells, NPC1, NPC2
and also cholesterol clearly colocalized (Figure 4G, inset). These
microscopic data reveal that Hrs knockdown causes cholesterol
accumulation in LE/Ly without affecting the localization of NPC1
and NPC2.
Hrs and Cholesterol Sorting
Here, we identify Hrs, but not other ESCRT components, as
a regulator of endosomal cholesterol trafficking. Compared
with other ESCRT components, Hrs is unique in at least two
aspects: (1) Hrs functions at the very beginning of the ESCRT
pathway, and therefore may have a critical role in cargo sorting
and the initiation of intralumenal vesicle (ILV) budding (Babst,
2011; Hurley et al., 2010). (2) Hrs has multiple interacting
partners that include many non-ESCRT components and has
been implicated in a number of trafficking/sorting events.
Besides STAM, clathrin and Tsg101, Hrs has also been re-
ported to interact with SNX1 and Vps35, components of the
retromer complex (Popoff et al., 2009). Moreover, Hrs, but
none of the other ESCRT components, is required for the
recycling of plasma membrane G protein coupled receptors
(Hanyaloglu et al., 2005). Together, it seems that the ability of
Hrs to interact with multiple partners forms the basis for its
multiple functions. Therefore, it is not entirely surprising
Figure 4. NPC1 and NPC2 Localize to Lamp-1
Positive Compartments in Hrs Knockdown Cells
HeLa cells were transfected with siCtrl (A and D), siNPC1
(B and E), siHrs (C and G), or siNPC2 (F) for 72 hr, followed
by processing for immunofluorescence staining with
antibodies to Lamp-1 or NPC1 (A–C), NPC1 or NPC2
(D–G), and filipin staining (A–G) for free cholesterol.
Representative confocal images are shown. Bars = 10 mm.that Hrs, but not other ESCRT components, is required for the
proper delivery of LDL-C.
Because of its well-established role in endosomal protein sort-
ing, one way Hrs may regulate cholesterol transport is through
controlling the level/degradation and localization of two endoso-
mal proteins: NPC1 and NPC2. However, NPC1 and NPC2 both
appear to be correctly localized upon Hrs knockdown (Figure 4).Cell Reports 1The level of NPC1 is upregulated by50%upon
Hrs depletion, whereas NPC2 is unchanged.
These results indicate that Hrs may regulate
the efflux of cholesterol from endosomes
through other mechanisms. Hrs may recruit
putative lipid carriers in the cytoplasm, and
facilitate cholesterol removal from the limiting
membrane. In support of such a hypothesis,
a genome-wide screen of Hrs-interacting
proteins identified ORP5 (Pridgeon et al.,
2009), which has recently been shown to
mediate endosomal cholesterol transport (Du
et al., 2011). We are currently examining the
detailed physical and functional relationship
between ORP5, Hrs, and NPC1. Additionally,
disturbed ILV formation upon Hrs knockdown
may further interrupt the efflux of LDL choles-
terol from LE/Ly as ILVs may play a role in the
storage and trafficking of lumenal cholesterol.
It is likely that the striking cholesterol accumula-
tion phenotype upon Hrs depletion results from
its combined effect on ILV formation, and on the
recruitment of cytoplasmic sterol carriers. In
summary, although further work is needed to
elucidate the interactions between NPC1,
ORP5, and Hrs, it is clear that Hrs can regulate
endosomal cholesterol sorting.
Hrs, Cholesterol, and Intralumenal
Budding
The ESCRT pathway is characterized by the
formation of ILVs through a unique mechanism,
i.e., membrane budding away from the cyto-
plasm. An important unanswered question is
what triggers the initial membrane deformation
in this budding event, although both lipids and
ESCRT proteins have been implicated (Babst,
2011; Hurley et al., 2010). Given the fact that
most coatless budding mechanisms rely on
membrane microdomains, it has been hypothe-
sized that the ESCRT-mediated budding could
involve cholesterol-rich domains, which mayinitiate the budding (Hurley et al., 2010). However, little is known
about how ESCRTsmay regulate the formation of suchmicrodo-
mains, which could form spontaneously as recently proposed
(Babst, 2011).
Here, a function of Hrs in endosomal cholesterol transport is
revealed. Hrs may initiate the ESCRT pathway by orchestrating
the formation of putative cholesterol rich microdomains that, 29–35, January 26, 2012 ª2012 The Authors 33
help drive the ‘‘budding away’’ from cytosol. In one hypothetical
scenario, Hrsmay selectively facilitate the removal of cholesterol
from specific regions of the limiting membrane, thereby gener-
ating a cholesterol rich neighboring region that forms the basis
of membrane deformation, which initiates the ESCRT pathway.
The potential role of Hrs in generating microdomains on the
endosomes may have broader implications. For instance, the
recycling of a prototypical sequence-dependent recycling
receptor, the beta-2 adrenergic receptor, is an active process
mediated by distinct endosomal subdomains that are stabilized
by a highly localized but dynamic actin machinery (Puthenveedu
et al., 2010). The fact that knocking down Hrs, but none of the
other ESCRT components, can significantly impair this recycling
pathway suggests that cholesterol-rich microdomains gener-
ated by Hrs may also be involved in the formation of this actin-
stabilized subdomain (Hanyaloglu et al., 2005).
In summary, our results uncover a role of Hrs in cholesterol
sorting and indicate that cholesterol efflux from endosomal
compartments and the formation of ILVs may be coregulated
by the multifunctional protein: Hrs.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
HeLa cells were purchased from the American Type Culture Collection (ATCC
HTB-22; Rockville, MD). Monolayers of cells were maintained in specified
medium supplemented with serum (medium A: 10% FBS; medium B: 5%
LPDS), 100 units/ml penicillin, and 100 mg/ml streptomycin sulfate in 5%
CO2 at 37
C. DNA transfection was performed using Lipofectamine LTX and
Plus Reagent (Invitrogen) according to manufacturer’s instruction. For each
transfection, 1–2 mg/well of plasmid cDNA were used in 6-well plates. siRNA
transfection was carried out in cells grown in medium A at 20% confluence
according to standard methods using Lipofectamine RNAiMAX transfection
reagent (Invitrogen). Forty picomoles of duplexes of siRNA were used for
transfection of one well of cells grown in 6-well plate.
Filipin Staining and Fluorescence Microscopy
Cells grown on coverslips were fixed with 4% paraformaldehyde for 30 min at
room temperature. Cells were stained with freshly prepared 50 mg/ml of filipin
in PBS for 1 hr at room temperature. Stained cells were imaged using a Leica
CTR5500 microscope (Wetzlar, Germany) equipped with an EL6000 fluores-
cent lamp and a DFC300 FX digital camera. Quantification of intracellular
free cholesterol was carried out as previously described (Du et al., 2011).
Immunofluorescence and Confocal Microscopy
All immunofluorescence steps were performed at room temperature and cells
were extensively rinsed with 3% BSA/PBS after each step. Cells grown on
glass coverslips were fixed with 4% paraformaldehyde for 15 min. For NPC2
staining, cells were fixed with Bouin’s solution (Sigma-Aldrich) for 1 hr at
room temperature. Cell permeabilization was carried out using 0.1% saponin/
PBS for 30 min, followed by blocking with 3% BSA/0.05% saponin in PBS
for 1 hr. Incubation with primary antibodies and appropriate conjugated
secondary antibodies were performed at room temperature for 1 hr. Cells
were mounted in ProLong Gold antifade reagent (Invitrogen). Confocal images
were acquired on an Olympus FV1000 laser-scanning microscope. The manu-
facturer’s software and Adobe Photoshop CS4 were used for data acquisition.
For colocalization analysis, Image-Pro Plus 6.0 software was used.
Cholesterol Esterification, SREBP-2 Processing,
and Immunoblotting Analysis
Cholesterol esterification, SREBP-2 processing, and immunoblotting analysis
were carried out as previously described (Du et al., 2006, 2011) and are
detailed in Supplemental Experimental Procedures.34 Cell Reports 1, 29–35, January 26, 2012 ª2012 The AuthorsSUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
three figures and can be found with this article online at doi:10.1016/j.celrep.
2011.10.004.
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